Skip to content
Welcome To Our Store.
100,000+ Products for Home, Medical, Office & Classroom Needs
Search
Skip to product information
1 of 1

Prolonged antibiotic therapy in PCR confirmed persistent Lyme disease - Paperback

$64.67
$64.67
Sale Sold out
Shipping calculated at checkout.
In stock (100 units), ready to be shipped

Available Offers

Fastest Delivery Tomorrow With Vip DealOrder within 1 hr 8 mins.

Instant 10% Discount On HDFC Banks Credit/Debit Cards EMI and CreditCard

Secure checkout with
  • American Express
  • Apple Pay
  • Diners Club
  • Discover
  • Google Pay
  • Mastercard
  • PayPal
  • Shop Pay
  • Visa

Flight Range: Up to 1,000 meters (3,280 feet)

Maximum Speed: 45 kilometers per hour (28 miles per hour)

For all orders exceeding a value of 100USD shipping is offered for free.

Returns will be accepted for up to 10 days of Customer’s receipt or tracking number on unworn items. You, as a Customer, are obliged to inform us via email before you return the item.

Otherwise, standard shipping charges apply. Check out our delivery Terms & Conditions for more details.

View Product Details
Shopping cart
Product Product subtotal Quantity Price Product subtotal
Prolonged antibiotic therapy in PCR confirmed persistent Lyme disease - Paperback
Prolonged antibiotic therapy in PCR confirmed persistent Lyme disease - Paperback
Prolonged antibiotic therapy in PCR confirmed persistent Lyme disease - Paperback
$64.67/ea
$0.00
$64.67/ea $0.00

Product Description

by Bernt-Dieter Huismans (Author)

We examined a sample of 90 individuals that had previously received a course of appropriate antibiotics for Lyme disease without experiencing full resolution of their symptoms and had evidence of persistent infection documented by PCR analysis. Mean duration of symptoms was 9.5 years (range 1 - 40 years). The treatment was adapted to the individual case according to clinical response. Long term antibiotic therapy was initiated and patients were treated continuously for at least 6 months, in some cases several years of intermittent therapy was administered. About 38.8% of the patients experienced full remission of symptoms while about 56.7% reported a significant improvement, 5.6% of patients were deemed refractory to therapy. Therapeutic modalities are discussed in detail.

Author Biography

Wolfgang Klemann, MD, Leopoldstr. 17, 75172 Pforzheim, Germany, Phone: +49 (0)7231 313159, Fax + 49 ( 0)7231 106161, http: //www.dr-w-klemann.de/ Email: w.klemann@dr-w-klemann.de, Bernt-Dieter Huismans, MD, Am Haldenberg 24, 74564 Crailsheim, Germany, Phone: +49 (0)7951 26 33 0, http: //www.huismans.de.vu, http: //www.erlebnishaft.de/ Email: BHuismans@t-online.de, Stephan Heyl, MD, Primelweg 13, 71229 Leonberg, Germany Email: stephan.heyl@googlemail.c

Number of Pages: 32
Dimensions: 0.08 x 8.27 x 5.83 IN
Publication Date: March 13, 2014
you might like